UK Biobank
|
UK
|
500,000
|
closed, population aged 40–69
|
blood, urine, saliva
|
yes
|
genotyping array, WGS, WES, metabolomics, telomere length
|
Bycroft et al., 2018 [37];
Wells et al., 2019 [38];
Watanabe et al., 2019 [26];
van Hout et al., 2020 [39];
Shikov et al., 2020 [27];
de Vincentis et al., 2022 [40];
Halldorsson et al., 2022 [15] |
BioBank Japan
|
Japan
|
267,307
|
closed, patient-based
|
serum, DNA, tumor tissues
|
yes
|
genotyping array, WGS, metabolome
|
Ishigaki et al., 2020 [41]; Matoba et al., 2020 [42] |
FinnGen
|
Finland
|
538,600
|
open, general population, 15 disease-specific cohorts
|
depends on sample collector b
|
depends on sample collector b
|
genotyping array
|
Desch et al., 2020 [43]; Kurki et al., 2022 [44]; Sun et al., 2022 [45] |
Estonian biobank
|
Estonia
|
200,000
|
open, adult population
|
whole blood and fractions, DNA, RNA
|
yes
|
WGS, WES, genotyping array, metabolomics (NMR), RNA seq., genome-wide methylation arrays, genome-wide gene expression array
|
Alver et al., 2019 [29]; Reisberg et al., 2019 [46] |
China Kadoorie Biobank
|
China
|
512,891
|
closed, residents of 5 urban and 5 rural provinces aged 30–79
|
blood
|
no
|
genotyping array, WGS
|
Spracklen et al., 2020 [47]; Giannakopoulou et al., 2020 [48]; Zhu et al., 2021 [49]; Li et al., 2022 [50] |
Tohoku Medical Megabank Project
|
Japan
|
157,000
|
closed, adult residents of Miyagi and Iwate Prefecture, three-generation cohort
|
blood fractions, urine, saliva, breast milk, dental plaque, stimulated T-cells, and EBV-transformed B-cells
|
yes
|
WGS, genotyping array, metabolomics (NMR, LC-MS), genome-wide methylation arrays
|
Watanabe et al., 2018 [51]; Tadaka et al., 2019 [52]; Tadaka et al., 2021 [53]; Kawame et al., 2022 [28]; Ohneda et al., 2022 [54]; Park, 2022 [55] |
Taiwan Biobank
|
Taiwan
|
181,635
|
open, population aged 20–70, patient-based
|
blood, urine, saliva
|
yes
|
genotyping array, WGS, DNA methylation, HLA typing, metabolomics
|
Weiet al., 2021 [56]; Lee at al., 2022 [57]; Juang et al., 2021 [58] |
LifeLines Cohort Study
|
Netherlands
|
167,000
|
closed, residents of the northern part of country
|
blood, urine, saliva, scalp hair
|
yes
|
genotyping array, WGS, microbiome data
|
Bonder et al., 2016 [59]; Imhann et al., 2016 [60]; Zhernakova et al., 2018 [61] |
National Biobank of Korea
|
South Korea
|
1,051,787
|
population-based, patient-based
|
blood fractions, urine, saliva, DNA, tissue
|
yes
|
genotyping array
|
Namet al., 2022 [62]; Moon et al., 2019 [63] |
Karolinska Biobank
|
Sweden
|
700,000
|
collection-specific
|
whole blood and fractions, urine, saliva, DNA
|
depends on collection
|
genotyping array
|
Bonfiglio et al., 2018 [64]
|
HUNT Biobank
|
Norway
|
120,000
|
open, adolescent and adult residents of Trøndelag
|
whole blood, plasma, serum, urine, saliva, feces, DNA
|
yes
|
genotyping array
|
Nielsen et al., 2018 [65]; Nielsen et al., 2020 [66]; Surakka et al., 2020 [67] |
Canadian Partnership for Tomorrow’s Health
|
Canada
|
331,359
|
open, residents of 9 provinces aged 30–74
|
whole blood and fractions, urine, saliva, dry blood spots, nail fragments
|
yes
|
genotyping array
|
Lona-Durazo et al., 2021 [68]; Joseph et al., 2022 [69] |
All of Us Research Program
|
USA
|
348,000
|
open, adult minority population
|
whole blood, urine, saliva
|
no
|
WGS, genotyping array
|
n.a.
|
BioVU
|
USA
|
275,000
|
open, pediatric and adult patient-based
|
DNA
|
yes
|
genotyping array
|
Zhenget al., 2021 [70]; Goldstein et al., 2020 [71]; Krebs et al., 2020 [72] |
Penn Medicine BioBank
|
USA
|
52,853
|
open, adult patient-based
|
blood, tissue
|
yes
|
genotyping array, WES
|
Parket al., 2021 [73]; Akbari et al., 2022 [74] |